Lisa Pleyer, MD^1,2,3,4*, Patrick Klammer, MSc^5*, Manuel Drost, MSc^5*, Hubert Angermann^6*, Felix Keil, MD^7*, Verena Petzer, MD^8*, Sonja Heibl, MD^9*, Jennifer Moritz, MD^10*, Michael Girschikofsky^11*, Margarete Stampfl-Mattersberger, MD^12*, Angelika Pichler, MD^13*, Bernd L. Hartmann, MD^14*, Gregor Aschauer, MD^15*, Clemens Schmitt^16,17, Sonia Vallet, MD^18*, Szilvia Boros, MD^19*, Petra Pichler^19*, Andrea Hammerl-Steiner, MD^20*, Felix Renneberg, MD^21*, Susanne Schnabel, MD^21*, Dilyan Majjiga, MD^21*, Thomas Melchardt, MD^1*, Alexander Egle, MD²¹, Michael Leisch, MD^21* and Richard Greil, MD^1,2,3,4

¹3rd Medical Dept. with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria
²Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria
³Salzburg Cancer Research Institute (SCRI), Center for Clinical Cancer and Immunology Trials (CCCIT), and Cancer Cluster Salzburg (CCS), Salzburg, Austria
⁴Laboratory for Molecular Cytology, Salzburg, Austria
⁵Assign Data Management and Biostatistics GmbH, Innsbruck, Austria
⁶Unidata Geodesign GmbH, Vienna, Austria
⁷Department of Haematology, Hanusch Krankenhaus, Wien, AUT
⁸Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Tirol, AUT
⁹4th Medical Dept. of Internal Medicine, Hematology, Internistic Oncology and Palliative Medicine, Klinikum Wels-Grieskirchen GmbH, Wels, AUT
¹⁰Division of Hematology, Medical University of Graz, Graz, Austria
¹¹Ordensklinikum, Linz Elisabethinen, Austria
¹²Department of Internal Medicine 2, Wiener Gesundheitsverbund, Klinik Donaustadt, Vienna, AUT
¹³LKH Hochsteiermark, Department of Internal Medicine, Hematology and Internal Oncology, Leoben, AUT
¹⁴Department of Internal Medicine 2, Landeskrankenhaus Feldkirch, Feldkirch, AUT
¹⁵Internal Medicine I: Medical Oncology and Hematology, Ordensklinikum Linz GmbH, Barmherzige Schwestern, Linz, AUT
¹⁶Kepler Universitätsklinik Linz, Linz, Austria
¹⁷Experimental and Clinical Research Center (ECRC), Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin, Berlin, Germany
¹⁸University Hospital Krems, Department of Internal Medicine 2, Karl Landsteiner Private University of Health Sciences, Krems, Austria
¹⁹Clinical Department for Internal Medicine, University Hospital St Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria
²⁰Department of Internal Medicine I, KH Barmherzige Brüder Graz, Graz, Austria
²¹3rd Medical Dept. with Haematology, Medical Oncology, Haemostaseology, Rheumatology and Infectiology, Oncologic Center, Paracelsus Medical University, Salzburg, Salzburg, Austria

Andrew Palmer, BS¹, Garth Rauscher^2*, Alexa Schoen^3*, Madelyn Burkart, M.D.⁴, Ashley Dunton^5*, Cherry Au^6*, Ami Dave^7*, Ahmad Nassar, MBBS⁸, Shaoshi Zhu^9*, Amani Erra^10*, Vinod Solipuram, MD^11*, Ivy Abraham^12*, Stephanie B. Tsai¹³, Maryam Zia, MD¹⁴, Melissa L. Larson¹⁵, Damiano Rondelli, MD^16*, Jessica K. Altman, MD¹⁷, Wendy Stock, MD¹⁸, Irum Khan, MD¹⁹, Olatoyosi Odenike, MD¹⁸ and Anand Ashwin Patel, MD¹⁸

¹University of Chicago Pritzker School of Medicine, Chicago, IL
²University of Illinois At Chicago School of Public Health, Chicago, IL
³Department of Medicine, Northwestern University, Chicago, IL
⁴Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
⁵Rush University, Chicago, IL
⁶Rush University, Chicago
⁷Division of Hematology, Oncology and Stem Cell Transplant, Rush University, Chicago
⁸University of Illinois Chicago, Chicago, IL
⁹University of Illinois College of Medicine, Chicago
¹⁰Division of Hematology and Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL
¹¹John H. Stroger Jr. Hospital of Cook County, Chicago
¹²UChicago Medicine, Flossmoor, IL
¹³Loyola University Medical Center, Chicago, IL
¹⁴Division of Hematology and Oncology, John H. Stroger Hospital of Cook County, Chicago, IL
¹⁵Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL
¹⁶Division of Hematology/Oncology, University of Illinois College of Medicine, Chicago, IL
¹⁷Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
¹⁸Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁹Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Amer M. Zeidan, MD¹, Yanqing Xu^2*, Tatyana A. Kapustyan^2*, Kaylee Miu^2*, Cheng Chen, PhD^3*, Rajesh Kamalakar^2*, Chia-Wei Lin^4*, Esprit Ma^4*, Melissa Montez^4*, Zheng Wu^5*, Tracy Yee^5*, Haiyan Sun^5*, Andrew Rava^5*, Sonia Kim^5* and Scott F Huntington¹

¹Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
²AbbVie, Inc., Health Economics and Outcomes Research – Oncology, Chicago, IL
³AbbVie, Inc, North Chicago, IL
⁴Genentech, Inc., South San Francisco, CA
⁵Genesis Research Group, Hoboken, NJ

Ella Johnson, BA^1*, Karan Bansal, MPH^2*, Chen Dai, MS^1*, Wajiha Mekki^2*, Sindhu Dwarampudi, BS^2*, Lindsey Hageman, MPH^2*, Joshua Knapp, BS^3*, Pankit Vachhani, MD^4*, Ravi Bhatia, MD⁴, Yohei Hisada, PhD^5*, Neil Zakai⁶, Smita Bhatia, MD, MPH² and Radhika Gangaraju, MD^7,8

¹Institute for Cancer Outcomes and Survivorship, University of Alabama At Birmingham, Birmingham, AL
²Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
³Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham
⁴Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
⁵Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC
⁶Division of Hematology and Oncology, University of Vermont, Burlington, VT
⁷Institute for Cancer Outcomes and Survivorship, University Of Alabama, Birmingham, AL
⁸Division of Hematology and Oncology, University Of Alabama at Birmingham, Birmingham, AL

Zaid Abdel Rahman, MD^1,2, Abeer Yaseen, MD^3*, Albatol Alamoush^4*, Lamya Abu Shanab^4*, Teeba Mubaydeen^4*, Rnad Khader^4*, Ahmad Alyamani^4*, Rand Al-Hadaddin^4*, Sulaiman Sayaydeh^4*, Omar Ahmad Shahin, MD^5*, Waleed Kamel Da'Na, MD^4*, Lina Marei, MD^4*, Kamal Alrabi, MD^4*, Yazan Talab, MD^4* and Mohammad Makoseh^4*

¹Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan
²University of Jordan, Amman, Jordan
³KIng Hussein Cancer Center, Amman, Jordan
⁴King Hussein Cancer Center, Amman, Jordan
⁵king Hussein cancer center internal medicine department, Amman, Jordan

Shireen J. Usman, MD¹, Jozal Moore, MD¹, Jane L. Liesveld, MD¹, Laura M. Calvi, M.D.¹ and Jason H. Mendler, MD, PhD²

¹Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
²University of Rochester Medical Center, Rochester, NY

Nisha Thiagarajah, MBBS, FRACP, FRCPA¹, Mark R Dowling, MBBS, PhD¹, Karin Dunne^2*, Donna Aarons^3*, Jenny Collins^4*, Steven Tran^5*, Shaun Fleming, MBBS, FRACP, FRACPA^6*, Gaurav Sutrave, MBBS, BSc, FRACP, FRCPA^7*, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA⁸, Chun Yew Fong, MBBS, FRACP, FRCPA, PhD^9*, Blake Hsu^10*, Duncan Purtill, MBBS, FRACP, FRCPA^11*, Anne-Marie Watson, FRACP, FRCPA^12*, Glen A Kennedy^13*, William S Stevenson, MBBS, FRACP, FRCPA, PhD^14*, Stephen Robert Larsen, MBBS PhD FRACP FRCPA¹⁵, John Moore, MBBS MD FRACP FRCPA¹⁶, Travis Perera, MBChB^17*, David S. Ritchie, MBChB PhD^1,18, Andrew Wei, MBBS, PhD^1,18*, Andrew W. Roberts, MBBS, PhD^1,18, Nada Hamad, MBBS, MSc, BSc^16,19,20 and Ashish Bajel, MBBS, FRACP, FRCPA^1,18

¹Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, VIC, Australia
²Australasian Leukaemia & Lymphoma Group, Melbourne, VIC, Australia
³Australia and New Zealand Transplant and Cellular Therapy Registry, Sydney, NSW, Australia
⁴Australasian Leukaemia and Lymphoma Group, Melbourne, VIC, Australia
⁵Australia and New Zealand Transplant and Cellular Therapies Registry, Darlinghurst, NSW, Australia
⁶Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, VIC, Australia
⁷Westmead Institute For Medical Research, Westmead, AUS
⁸Royal Adelaide Hospital, Adelaide, SA, Australia
⁹Department of Hematology, Austin Health, Heidelberg, VIC, Australia
¹⁰Department of Haematology, Christchurch Hospital, Christchurch, New Zealand
¹¹Haematology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
¹²Haematology, Liverpool Hospital, Sydney, Australia
¹³Haematology and Bone Marrow Transplant, Royal Brisbane and Women's Hospital, Herston, QLD, Australia
¹⁴Royal North Shore Hospital, Sydney, AUS
¹⁵Royal Prince Alfred Hospital, Camperdown, Australia
¹⁶Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
¹⁷Wellington Blood and Cancer Centre, Wellington Hospital, Wellington South, New Zealand
¹⁸Department of Medicine, University of Melbourne, Melbourne, VIC, Australia
¹⁹School of Clinical Medicine, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia
²⁰School of Medicine, University of Notre Dame, Sydney, Australia

Elena Crisa, MD^1*, Daniela Cilloni, MD^2*, Marta Riva^3*, Enrico Balleari, MD^4*, Daniela Barraco, MD^5*, Lorenza Borin, MD^6*, Michela Calmasini^7*, Anna Calvisi, MD^8*, Isabella Capodanno, MD^9*, Matteo Giovanni Della Porta, MD^10*, Elisa Diral, MD^11*, Bruno Fattizzo, MD¹², Susanna Fenu, MD^13*, Stefania Paolini, MD, PhD^14*, Carlo Finelli, MD^14*, Claudio Fozza, MD^15*, Chiara Frairia, MD^16*, Valentina Giai, MD, PhD^17*, Mauro Turrini, MD^18*, Maria Antonia Isoni, MD^19*, Federico Itri, MD^20*, Luca Maurillo, MD^21*, Alfredo Molteni, MD^22*, Giuseppe Alberto Palumbo, MD^23*, Anna Maria Pelizzari, MD^24*, Federica Pilo, MD^25*, Antonella Poloni, PhD^26*, Costanza Bosi, MD^27*, Grazia Sanpaolo, MD^28*, Rosaria Sancetta, MD^29*, Cristina Amato, SN^30*, Valeria Santini, MD³⁰, Maria Teresa Voso, MD³¹, Sam Salek^32*, Tatyana Ionova^33*, Annamaria Nosari, MD^34* and Esther Natalie Oliva, MD³⁵

¹Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
²Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
³Department of Hematology and Oncology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
⁴IRCCS Policlinico Ospedale San Martino, Genova, Italy
⁵Dipartimento di Ematologia - ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
⁶Hematology, Irccs San Gerardo di Monza, Monza, ITA
⁷Associazione Italiana Pazienti Sindromi Mielodisplastica AIPASIM, milano, Italy
⁸SC Ematologia,CTMO e Laboratorio specialistico, Ospedale S Francesco, Nuoro, Italy
⁹Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
¹⁰IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
¹¹Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
¹²Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
¹³Hematology and Stem Cell Transplant, St. Giovanni Addolorata Hospital, Rome, Italy
¹⁴IRCCS Azienda Ospedaliero-Universitaria di Bologna – Institute of Hematology “Seràgnoli", Bologna, Italy
¹⁵Hematology Unit – Azienda Ospedaliera Universitaria of Sassari, University of Sassari, Sassari, Italy
¹⁶Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy
¹⁷Hematology, AOU Città della Salute e della Scienza di Torino, Turin, Italy
¹⁸Hematology Unit, Division of Hematology, Valduce Hospital, Como, Como, Italy
¹⁹Istituto di Ematologia, Università di Sassari, Sassari, Italy, sassari, Italy
²⁰Dipartimento di Scienze Cliniche e Biologiche, AOU San Luigi Gonzaga, Orbassano, Italy
²¹Department of Onco-Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy
²²Ospedale Niguarda Ca' Granda, Milano, ITA
²³Department of Scienze Mediche, Chirurgiche e Tecnologie Avanzate “G.F. Ingrassia”, University of Catania, Catania, Italy
²⁴ASST Spedali Civili Di, Brescia, Italy
²⁵Hematology and BMT Unit, A.Businco hospital, Cagliari, Italy
²⁶Hematology Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Ancona, Italy
²⁷Ematologia e Centro Trapianti, Ospedale Guglielmo di saliceto, Piacenza, Italy
²⁸Hematology Unit, IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy
²⁹Hematology Unit, Dell'Angelo Hospital, Venezia-Mestre, Italy
³⁰MDS Unit, Hematology, DMSC, AOU Careggi, University of Florence, Florence, Italy
³¹Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
³²School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom
³³St. Petersburg State University Hospital, Saint-Petersburg, Russian Federation
³⁴Associazione Italiana Pazienti Sindromi Mielodisplastica AIPASIM, Milano, ITA
³⁵Hematology Unit, Grande Ospedale Metropolitano BMM, Reggio Calabria, Reggio Calabria, Italy

Jesus D Gonzalez-Lugo, MD¹, Yazan F Madanat, MD², Nidia Zapata, MD³, Deedra Nicolet, MS^4*, Victoria Klein, MS^4*, Charles Foucar, MD⁵, Krzysztof Mrózek, MD, PhD⁴, Nicole Twardowski, DO¹, Sharlene Dong, MD⁶, Haitham Abdelhakim, MD¹, Ana Varela Constantino, MD^7*, Judith Cruz Velazquez^3*, Diana Arcos^3*, Angelica Santiago Medina^3*, Jose Ramiro Espinoza Zamora, MD^3*, Alice Mims, MD⁴, Tara L. Lin, MD¹, Ann-Kathrin Eisfeld, MD⁸, Onyee Chan, MD⁹ and Andres Gomez-De Leon, MD¹⁰

¹Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS
²Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
³Instituto Nacional de Cancerologia, Mexico City, Mexico
⁴The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁵University of New Mexico, Ann Arbor, MI
⁶University of Texas Southwestern Medical Center, Dallas, TX
⁷Tec Salud, Instituto Tecnologico de Estudios Superiores de Monterrey, Monterrey, Mexico
⁸The Ohio State University, Columbus, OH
⁹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁰Universidad Autonoma de Nuevo Leon. Facultad de Medicina y Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico

John X Wei, MD¹, Mendel Goldfinger^2*, Marina Konopleva, MD³, Ioannis Mantzaris, MD², Amit Verma, MD⁴ and Eric J. Feldman, MD^5*

¹Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
²Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
³Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
⁴Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
⁵Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

Cassandra Duarte, MD¹, Diana Abbott, PhD², Christine M. McMahon, MD³, Andrew Kent, MD, PhD⁴, Marc Schwartz, MD⁵, Jonathan Gutman, MD⁴, Daniel A Pollyea, MD⁵ and Maria L Amaya, MD, PhD⁶

¹University of Colorado Cancer Center, Denver, CO
²Center for Innovative Design and Analysis (CIDA), Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO
³Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
⁴Division of Hematology, University of Colorado, Aurora, CO
⁵Division of Hematology, University of Colorado, Denver, CO
⁶University of Colorado, Aurora, CO

Andrew T. Kuykendall, MD¹, Francesca Palandri, MD, PhD^2*, Shiyuan Zhang, MSc^3*, Tom Liu, MS^3*, Mirko Fillbrunn, PhD^4*, Adina Zhang^4*, Gautam Sajeev, D.Sc^4*, James Signorovitch, PhD^4*, Dwaipayan Patnaik, MD, MBBS⁵ and Aaron T. Gerds, MD, MS⁶

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Istituto di Ematologia "Seràgnoli", Bologna, Italy
³GSK plc, Collegeville, PA
⁴Analysis Group, Inc., Boston, MA
⁵GSK plc, Baar, Switzerland
⁶Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Ian Thomas^1*, Joanna Canham^2*, Sean Johnson^3*, Nuria Marquez^4*, Sophie King^1*, Jane Leahy^5*, Mike Dennis, MD, MRCP, FRCPath⁶, Nigel H. Russell, MD⁷, Abin Thomas^1* and Steven Knapper, DM⁸

¹Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
²Cardiff University, Cardiff, WAL, GBR
³Cardiff University, Cardiff, United Kingdom
⁴Cardiff University, Cardiff, GBR
⁵Private affiliation, PPI Representative, London, United Kingdom
⁶The Christie NHS Foundation Trust, Manchester, United Kingdom
⁷Nottingham University Hospital (City Hospital Campus), Nottingham, ENG, United Kingdom
⁸Univ. Hosp. of Wales, Cardiff, GBR

Ashley C. Woods, MD^1*, Dianne D. Pulte, MD¹, Kamar Godder, MD^1*, Emily Jen, MD, PhD^1*, Nina Kim^2*, Robert Le, MD^1*, Catherine C. Lerro, MPH, PhD^3*, Donna Rivera, MS, PharmD^4*, Gulsum Pamuk, MD^1*, Nicole J. Gormley, MD^1*, Marc R. Theoret, MD^5*, Kelly J. Norsworthy, MD^2* and R. Angelo De Claro, MD^2*

¹US Food and Drug Administration, Silver Spring, MD
²U.S. Food and Drug Administration, Silver Spring, MD
³Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD
⁴Oncology Center or Excellence, US Food and Drug Administration, Silver Spring, MD
⁵Center for Drug Evaluation and Research, Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD

John O. Mascarenhas, MD¹, Aaron R. Perkins^2*, Yu-Hsuan Shih^3*, Derek Tang^3*, Sara Vergara^3* and Carlos A. Alvarez^2*

¹Icahn School of Medicine at Mount Sinai, New York, NY
²Texas Tech University Health Sciences Center and Center for Excellence in Real-World Evidence, Dallas, TX
³Bristol Myers Squibb, Princeton, NJ

Manuel Espinoza-Gutarra, MD¹, Brooke Jarrett, PhD^2*, Xiaoliang (Wendy) Wang, PhD³, Anosheh Afghahi, MD^2,4* and Sejong Bae, PhD^5*

¹O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL
²Flatiron Health, New York, NY
³Flatiron Health, INC., New York, NY
⁴University of Colorado School of Medicine, Aurora, CO
⁵O'Neal Comprehensive Cancer Center at UAB, Birmingham, AL

Rahul Mishra, MBBS¹, Noha Sharafeldin, PhD, MSc², Ruchi Desai, MD^3*, Pankit Vachhani, MD^4* and Tania Jain, MD⁵

¹Department of Internal Medicine, Anne Arundel Medical Center, Annapolis, MD
²Division of Hematology and Oncology, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL
³Department of Medicine, Division of Hematology, Oncology, and Palliative Care, Virginia Commonwealth University, Richmond, VA
⁴Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
⁵Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Maria Agustina Perusini, Eleanore Louise Musick^*, Filza Gul^*, May Chiu^*, Mohammad Alwadi^*, Noora Obaidallah^*, Jaeyoon John Kim^*, Danielle Pyne^*, Jose-Mario Capo-Chichi, PhD^* and Dennis Dong Hwan Kim, MD, PhD

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Chi-Joan How, MD¹, Bridget Coffey^2*, Christina M. Dieli-Conwright^3*, Gabriela S. Hobbs, MD⁴, Hermioni L Amonoo, MD⁵, Areej El-Jawahri, MD⁶ and Richard Newcomb, MD^7*

¹Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
²Massachusetts General Hospital, Boston
³Dana Farber Cancer Institute, Boston
⁴Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
⁵Harvard Medical School, Boston, MA
⁶Massachusetts General Hospital, Allston, MA
⁷Massachusetts General Hospital, Winthrop, MA

Ehab L. Atallah, MD¹, Islam Sadek, MD^2*, David Wei, PhD^2*, Dominick Latremouille-Viau, MSc^3*, Carmine Rossi^3*, Andrea Damon, PhD^2*, Daisy Yang, PharmD, BCOP^2*, Remi Bellefleur^3*, Annie Guérin, MS^4* and Kejal Jadhav, B.Pharm, MS^2*

¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
²Novartis Pharmaceuticals Corporation, East Hanover, NJ
³Analysis Group, Inc., Montreal, QC, Canada
⁴Analysis Group, Inc, Montreal, Canada

Naveen Pemmaraju, MD¹, Jingbo Yu, MD, PhD^2*, Anupama Vasudevan, BDS, MPH, PhD^3*, Husain Qureshi, MBBS, MBA^4*, Evan M. Braunstein, MD, PhD^2* and Aleksander L. Chojecki, MD⁵

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
²Incyte Corporation, Wilmington, DE
³IntegraConnect PrecisionQ, West Palm Beach, FL
⁴Integra Connect Precision Q, West Palm Beach, FL
⁵Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC

Michael Marrone, PhD^1*, Lisa Morere^2*, Abiola Oladapo, PhD, MSc, BPharm^3*, Purvi Suthar, PharmD^1*, Teena Sura^2*, Anupama Vasudevan, BDS, MPH, PhD^4*, Michael Vredenburg, PhD^1*, Jia Zeng, PhD^2*, Raajit Rampal, MD, PhD⁵ and John O. Mascarenhas, MD⁶

¹Sobi Inc., Waltham, MA
²IntegraConnect, PrecisionQ, West Palm Beach, FL
³Sobi, Inc., Waltham, Massachusetts, USA, Waltham, MA
⁴IntegraConnect PrecisionQ, West Palm Beach, FL
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Thomas W. LeBlanc, MD, MA, MS¹, Hannah Collacott^2*, Valentín García Gutiérrez Sr.³, Ned Weinshenker^4*, Ruth Fein Revell^5*, Alicia O'Neill, MA^6*, Anna P Cardellino^6*, Shiyuan Zhang, MSc^6*, Dwaipayan Patnaik, MD, MBBS⁷ and Melissa Ross^2*

¹Duke Cancer Institute, Hillsborough, NC
²Evidera, Bethesda, MD
³Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁴Churchill Oaks Consulting and Myelofibrosis Patient Advocate, Salt Lake City, UT
⁵Health/Life Sciences Writer and Chronic Cancer Patient Advocate, Saratoga Springs, NY
⁶GSK plc, Collegeville, PA
⁷GSK plc, Baar, Switzerland

Elias Jabbour^1*, Delphine Rea², Mouna Bardey-Kanaan^3*, Romuald Soichez^3*, Nhan Thanh Nguyen^3*, Deborah Kelly^3*, Federica Rizzo^3*, Petros Patos^3* and Valentín García Gutiérrez Sr.⁴

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hématologie, Hôpital Saint-Louis, Paris, France
³Incyte Biosciences International Sàrl, Morges, Switzerland
⁴Departamento de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain

Mahesh Swaminathan, MD¹, Hussein A. Abbas, MD, PhD¹, Guillermo Garcia-Manero, MD¹, Naval Daver, MD², Tapan M. Kadia, MD¹, Courtney D. DiNardo, MD, MSc³, Gautam Borthakur, MD⁴, Elias Jabbour, MD⁵, Naveen Pemmaraju, MD⁶, Yesid Alvarado Valero, MD¹, Maro Ohanian, DO^1*, Nitin Jain, MD¹, Nicholas J. Short, MD¹, Prithviraj Bose, MD⁷, Koichi Takahashi, MD, PhD¹, Hyunsoo Hwang, MS^8*, Xuelin Huang, PhD^8*, Paul Edelkamp Jr.^9*, Sherry Pierce, BSN, BA^1*, Uday Popat, MD¹⁰, Elizabeth J. Shpall, MD¹⁰, Richard E. Champlin, MD¹⁰, Hagop M. Kantarjian, MD¹ and Farhad Ravandi, MBBS¹¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
⁷The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Enterprise Data Engineering & Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Philipp Berning^1*, David Baden, MD^2*, Philipp Faustmann, MD^3*, Snjezana Janjetovic^4*, Hanna Katharina Zieger^5*, Jan Christian Schroeder^3*, Giuliano Filippini Velazquez, MD^6*, Anna Ossami Saidy^4*, Hristo Boyadzhiev^7,8*, Tim Sauer, MD⁹, Jan-Henrik Mikesch, MD^1*, Niklas Gebauer^10*, Susanne Ghandili, MD^11*, Paul J. Bröckelmann, MD^12*, Friederike Hildebrand^13*, Veit L. Buecklein, MD^13*, Rebecca Wurm-Kuczera, MD^14*, Ulrich Keller^14*, Georg Lenz¹, Thomas Pabst⁷, Thomas Melchardt, MD^15*, Claudia Lengerke, MD³, Maher Hanoun, MD, PhD^5*, Evgenii Shumilov^1* and Ulrike Bacher^16*

¹Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
²Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
³Department for Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
⁴Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
⁵Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
⁶Department of Hematology, University Hospital Augsburg, Augsburg, Germany
⁷Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
⁸Habichtswald Hospital, Kassel, Germany
⁹Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
¹⁰Department for Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
¹¹Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹²University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
¹³Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
¹⁴Hematology, Oncology and Cancer Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany
¹⁵Paracelsus Medical University, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria
¹⁶Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland